Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Women’s and men’s health strategies offer a shared agenda for reform

England now has national strategies for women’s1 and men’s health,2 marking an important policy moment in which sex […]

July 8, 2026 Uncategorized

Grünenthal receives FDA designations for tegacorat in Duchenne muscular dystrophy

Grünenthal receives FDA designations for tegacorat in Duchenne muscular dystrophy
p p Read More

SEGRAM aims to offer an alternative to glucocorticoid‑based treatment

July 8, 2026 News

New weight loss pill beats oral Ozempic in major trial

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading […]

July 8, 2026 Uncategorized

Creatine doesn’t just build muscle. It may also help fight cancer

Scientists have discovered that creatine may strengthen one of the immune system’s most important cancer-fighting pathways by energizing […]

July 8, 2026 Uncategorized

Delayed discharges: Annual cost rises to almost {pound}2.7bn in past year

The NHS in England is now paying £2.7bn a year for delayed discharges, says a new analysis, putting […]

July 8, 2026 Uncategorized

John Launer: I hope GPs will continue to value “mosaic care”

A common stereotype of GPs’ work—held by some politicians and hospital specialists, as well as members of the […]

July 8, 2026 Uncategorized

Endometriosis: “Game changing” new tests may speed up diagnosis in primary care

Two non-invasive tests can now be used to speed up the diagnosis of endometriosis in primary care while […]

July 8, 2026 Uncategorized

Helen Salisbury: Missed appointments and missingness

When patients miss an outpatient appointment they are sent a letter, and an electronic copy goes to their […]

July 8, 2026 Uncategorized

Compass Pathways reports six‑month data confirming durable profile of COMP360

Compass Pathways reports six‑month data confirming durable profile of COMP360
p p Read More

Second phase 3 trial shows sustained benefit and supports forthcoming regulatory submission

July 7, 2026 News

Ferrer and Prilenia begin confirmatory study of pridopidine in Huntington’s disease

Ferrer and Prilenia begin confirmatory study of pridopidine in Huntington’s disease
p p Read More

New phase 3 trial to assess impact on disease progression, function and quality of life

July 7, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 2,008 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy